BioSpace News Archive

Bridge Biotherapeutics (KQ288330) announced that it is presenting a poster on its preclinical drug candidate BBT-207 at the American Association for Cancer Research (AACR) 2023 annual meeting taking place on April 14-19 in Orlando, Florida.

CorEvitas, LLC (“CorEvitas”), a leading provider of syndicated registries, is pleased to share important safety information regarding mRNA COVID-19 vaccines and their use in pregnant people.

Nymox Pharmaceutical Corporation has officially been granted by NASDAQ an additional period until July 3, 2023 to regain compliance with NASDAQ listing requirements, the Company reported.

BioVentrix®, Inc. today announced the publication of a peer-reviewed paper in the Journal of Clinical Medicine, titled, Inward Displacement, A Novel Approach to Measuring Left Ventricular (LV) Function in Patients with HFrEF after Undergoing BioVentrix Therapy.

Sequential Skin Inc. announced that it has entered into a collaboration agreement with Johnson & Johnson Consumer Inc.

Trethera Corporation (“Trethera”) received a unanimous recommendation from the independent safety review committee (“SRC”) to continue clinical trial advancement of Trethera’s lead development asset, TRE-515, its first-in-class deoxycytidine kinase (“dCK”) inhibitor.

IMUNON, Inc.(NASDAQ: IMNN), a clinical-stage drug development company, today announced that an abstract related to the Company’s DNA-based immunotherapy has been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting, being held April 14-19 at the Orange County Convention Center in Orlando, FL and virtually.

Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces its results for fiscal year 2022 and reviews its clinical and scientific news and recent strategic advances.

OncoResponse today announced a poster presentation at the upcoming American Association for Cancer Research Annual Meeting being held April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.

Matinas BioPharma, a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal platform delivery technology, reports 2022 financial results and provides a business update.